Exon 20 PIK3CA mutations decreases survival in aggressive (HER-2 positive) breast carcinomas

This publication has 30 references indexed in Scilit:

• PIK3CA Exon 20 Mutation is Independently Associated with a Poor Prognosis in Breast Cancer Patients
  Annals of Surgical Oncology, 2008
• Different Prognostic Roles of Mutations in the Helical and Kinase Domains of the PIK3CA Gene in Breast Carcinomas
  Clinical Cancer Research, 2007
• Poor prognosis in carcinoma is associated with a gene expression signature of aberrant PTEN tumor suppressor pathway activity
  Proceedings of the National Academy of Sciences, 2007
• Correlation of PIK3Ca mutations with gene expression and drug sensitivity in NCI-60 cell lines
  Biochemical and Biophysical Research Communications, 2006
• Phosphoinositide 3-kinases as drug targets in cancer
  Current Opinion in Pharmacology, 2005
• Frequent Mutation of the PIK3CA Gene in Ovarian and Breast Cancers
  Clinical Cancer Research, 2005
• PIK3CA gene is frequently mutated in breast carcinomas and hepatocellular carcinomas
  Oncogene, 2004
• Mutation of the PIK3CA Gene in Ovarian and Breast Cancer
  Cancer Research, 2004
• The phosphatidylinositol 3-Kinase–AKT pathway in human cancer
  Nature Reviews Cancer, 2002
• Molecular portraits of human breast tumours
  Nature, 2000